Literature DB >> 16000144

Phosphorylation of tau at serine 416 by Ca2+/calmodulin-dependent protein kinase II in neuronal soma in brain.

Hideyuki Yamamoto1, Yukari Hiragami, Miyuki Murayama, Koko Ishizuka, Masahiro Kawahara, Akihiko Takashima.   

Abstract

It is well known that tau is a good in vitro substrate for Ca2+/calmodulin-dependent protein kinase II (CaM kinase II). However, it is not clear at present whether CaM kinase II phosphorylates tau in vivo or not. Serine 416, numbered according to the longest human tau isoform, has been reported to be one of the major phosphorylation sites by CaM kinase II in vitro. In this study, we produced a specific antibody against tau phosphorylated at serine 416 (PS416-tau). Immunoblot analysis revealed that the antibody reacted with tau in the rat brain extract which was prepared in the presence of protein phosphatase inhibitors. Developmental study indicated that serine 416 was strongly phosphorylated at early developmental stages in rat brain. We examined the localization of PS416-tau in primary cultured hippocampal neurons and the immortalized GnRH neurons (GT1-7 cells), which were stably transfected with CaM kinase IIalpha cDNA. Immunostaining of these cells indicated that tau was phosphorylated mainly in neuronal soma. Interestingly, tau in neuronal soma in Alzheimer's disease (AD) brain was strongly immunostained by the antibody. These results suggest that CaM kinase II is involved in the accumulation of tau in neuronal soma in AD brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000144     DOI: 10.1111/j.1471-4159.2005.03307.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

Review 2.  Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Authors:  Thimmappa S Anekonda; Joseph F Quinn
Journal:  Biochim Biophys Acta       Date:  2011-09-08

3.  Depotentiation of Long-Term Potentiation Is Associated with Epitope-Specific Tau Hyper-/Hypophosphorylation in the Hippocampus of Adult Rats.

Authors:  Ercan Babür; Burak Tan; Sumeyra Delibaş; Marwa Yousef; Nurcan Dursun; Cem Süer
Journal:  J Mol Neurosci       Date:  2018-11-29       Impact factor: 3.444

4.  Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.

Authors:  Alessandro Didonna; Ester Cantó; Hengameh Shams; Noriko Isobe; Chao Zhao; Stacy J Caillier; Carlo Condello; Hana Yamate-Morgan; Seema K Tiwari-Woodruff; Mohammad R K Mofrad; Stephen L Hauser; Jorge R Oksenberg
Journal:  J Autoimmun       Date:  2019-04-19       Impact factor: 7.094

5.  Ca2+/calmodulin-dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy.

Authors:  Mikiko Oka; Naoki Fujisaki; Akiko Maruko-Otake; Yosuke Ohtake; Sawako Shimizu; Taro Saito; Shin-Ichi Hisanaga; Koichi M Iijima; Kanae Ando
Journal:  J Biochem       Date:  2017-11-01       Impact factor: 3.387

Review 6.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

7.  Calmodulin Binding Proteins and Alzheimer's Disease.

Authors:  Danton H O'Day; Kristeen Eshak; Michael A Myre
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus.

Authors:  Cem Süer; Nurbanu Yıldız; Özlem Barutçu; Burak Tan; Nurcan Dursun
Journal:  Pharmacol Rep       Date:  2021-04-02       Impact factor: 3.024

Review 9.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.

Authors:  Pei-Pei Guan; Long-Long Cao; Pu Wang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Calcium/calmodulin-dependent kinase II and Alzheimer's disease.

Authors:  Anshua Ghosh; Karl Peter Giese
Journal:  Mol Brain       Date:  2015-11-24       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.